Literature DB >> 3080234

Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.

P J Pera, D L Kramer, J R Sufrin, C W Porter.   

Abstract

The effects of the enzyme-activated irreversible inhibitors of ornithine decarboxylase, alpha-difluoromethylornithine, alpha-(fluoromethyl)dehydroornithine, alpha-(fluoromethyl)dehydroornithine methyl ester, and (2R,5R)-6-heptyne-2,5-diamine (RR-MAP), on cell growth and parameters related to polyamine biosynthesis were compared in L5178Y and L1210 cells under identical culture conditions. The two lines are murine lymphocytic leukemia cells which differ in their ability to metabolize 5'-methylthioadenosine, the by-product of polyamine biosynthesis: L5178Y cells contain a specific 5'-methylthioadenosine phosphorylase; L1210 cells do not. In L1210 cells, the 50% inhibitory concentrations (lC50S) of the various analogues were 3.0 mM for alpha-difluoromethylornithine, 0.2 mM for alpha-(fluoromethyl)dehydroornithine, 0.1 mM for alpha-(fluoromethyl)dehydroornithine methyl ester, and 0.01 mM for RR-MAP. L5178Y cells were somewhat more sensitive to the inhibitors with lC50 values of 0.5 mM for alpha-difluoromethylornithine, 0.06 mM for alpha-(fluoromethyl)dehydroornithine, 0.03 mM for alpha-(fluoromethyl)dehydroornithine methyl ester, and 0.002 mM for RR-MAP. In all cases, growth inhibition was fully prevented by exogenous putrescine. The effects of the inhibitors on parameters related to polyamine metabolism were compared at drug concentrations approximating the average of lC50 values for the two cell lines. Under these treatment conditions, polyamine pools were similarly affected by the various inhibitors. Typically, putrescine and spermidine were depleted, but effects on spermine pools differed according to the cell line, increasing slightly in L1210 cells and decreasing by about 50% in L5178Y cells. Spermine pools in L1210 cells could be reduced by RR-MAP at concentrations higher than the lC50 (i.e., 0.1 mM). Clonogenicity in soft agar was decreased about 50% by putrescine and spermidine depletion and was not further affected by spermine depletion. The inhibitors elevated S-adenosylmethionine decarboxylase activity in both cell lines with a 2-fold greater increase in L5178Y cells than in L1210 cells. Finally, the inhibitors decreased S-adenosylmethionine pools in L1210 cells by about 50% but had little effect on these pools in L5178Y cells with the exception of RR-MAP, which decreased S-adenosylmethionine pools by about 40%. Whether the different polyamine responses of the two cell lines are related to their ability to metabolize 5'-methylthioadenosine is uncertain. It is apparent, however, that the presence or absence of methylthioadenosine phosphorylase does not substantially modulate the antiproliferative activity of ornithine decarboxylase inhibitors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080234

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1 N12-bis(ethyl)spermine.

Authors:  C W Porter; A E Pegg; B Ganis; R Madhabala; R J Bergeron
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

2.  Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis.

Authors:  M A Cornbleet; A Kingsnorth; G P Tell; K D Haegele; A M Joder-Ohlenbusch; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma.

Authors:  J A Ajani; D M Ota; V B Grossie; J L Abbruzzese; J S Faintuch; Y Z Patt; D E Jackson; B Levin; K Nishioka
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine.

Authors:  C W Porter; F G Berger; A E Pegg; B Ganis; R J Bergeron
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

5.  Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy.

Authors:  P J Creaven; R Perez; L Pendyala; N J Meropol; G Loewen; E Levine; E Berghorn; D Raghavan
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.

Authors:  R Danesi; A Marchetti; N Bernardini; R V La Rocca; G Bevilacqua; M Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Rapid activation of glycogen phosphorylase by steroid hormones in cultured rat hepatocytes.

Authors:  A Gomez-Muñoz; P Hales; D N Brindley; M J Sancho
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

8.  Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics.

Authors:  M Saminathan; Thresia Thomas; Akira Shirahata; C K S Pillai; T J Thomas
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

Review 9.  Polyamines in brain tumor therapy.

Authors:  E S Redgate; S Boggs; A Grudziak; M Deutsch
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.

Authors:  F Derouin; C Chastang
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.